How GLP-1s impact the heart and kidneys of veterans with type 2 diabetes

Public interest in drugs known as glucagon-like peptide-1 receptor agonists, also called GLP-1 RAs, has surged in recent years, with popular types like semaglutide (sold under brand names like Ozempic and Wegovy) becoming known for their weight-loss effects.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup